Skip to content

ASCOT: Lifestyle study for cancer survivors

Advancing Survivorship after Cancer: Outcomes Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN17421871
Enrollment
5000
Registered
2015-07-29
Start date
2015-05-20
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Topic: Cancer

Interventions

ASCOT is a lifestyle intervention (a leaflet developed in consultation with clinicians and patients, a phone consultation and a website) aimed at helping cancer patients adhere to the World Cancer Res

Sponsors

University College London Joint Research Office
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Current inclusion criteria as of 18/12/2020: ASCOT patient survey: All individuals diagnosed with breast, prostate or colorectal cancer in 2012-2015 at an NHS trust in London or Essex. ASCOT pilot trial: 1. Adults aged at least18 years (no upper age limit) 2. Individuals diagnosed with non-metastatic breast, prostate or colorectal cancer in 2012-2015 3. Individuals not receiving active anti-cancer treatment (except for those oral anti-cancer treatments taken at home who can be included) 4. Individuals who are able to understand spoken and written English Previous inclusion criteria: ASCOT patient survey: All individuals diagnosed with breast, prostate or colorectal cancer in 2012 or 2013 at an NHS trust in London or Essex. ASCOT pilot trial: 1. Adults aged at least18 years (no upper age limit) 2. Individuals diagnosed with non-metastatic breast, prostate or colorectal cancer in 2012 or 2013 3. Individuals not receiving active anti-cancer treatment (except for those oral anti-cancer treatments taken at home who can be included) 4. Individuals who are able to understand spoken and written English

Exclusion criteria

Exclusion criteria: ASCOT pilot trial: 1. Individuals with metastatic disease 2. Individuals on active anti-cancer treatment requiring hospital admission 3. Individuals with severe cognitive impairment

Design outcomes

Primary

MeasureTime frame
Current primary outcome measures (as of 10/01/2018) Composite health behaviour risk index; Timepoint(s): 0, 3, 6 and 24 months Previous primary outcome measures Composite health behaviour risk index; Timepoint(s): 0, 3 and 6 months

Secondary

MeasureTime frame
Current secondary outcome measures (as of 10/01/2018) 1. Alcohol (AUDIT C questionnaire); Timepoint(s): 0, 3, 6 and 24 months 2. Dietary intake (24 hour dietary recall phone calls); Timepoint(s): 0, 3, 6 and 24 months 3. Physical activity (pedometer and questionnaire); Timepoint(s): 0, 3, 6 and 24 months 4. Quality of Life (EQ-5D-5L); Timepoint(s): 0, 3, 6 and 24 months 5. Sleep (questionnaire); Timepoint(s): 0, 3, 6 and 24 months 6. Smoking status (questionnaire); Timepoint(s): 0, 3, 6 and 24 months Previous secondary outcome measures 1. Alcohol (AUDIT C questionnaire); Timepoint(s): 0, 3 and 6 months 2. Dietary intake (24 hour dietary recall phone calls); Timepoint(s): 0, 3 and 6 months 3. Physical activity (pedometer and questionnaire); Timepoint(s): 0, 3 and 6 months 4. Quality of Life (EQ-5D-5L); Timepoint(s): 0, 3 and 6 months 5. Sleep (questionnaire); Timepoint(s): 0, 3 and 6 months 6. Smoking status (questionnaire); Timepoint(s): 0, 3 and 6 months

Countries

England, United Kingdom

Contacts

Public ContactRebecca Beeken
r.beeken@leeds.ac.uk+44 (0)113 3430741

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026